'U' curve association of blood pressure and mortality in hemodialysis patients

Kidney International

Volumn 54, Issue 2, 1998, Pages 561-569

  Zager, Philip G ^a   Nikolic, Jovanka ^b   Brown, Richard H ^b   Campbell, Marilyn A ^b   Hunt, William C ^b   Peterson, Darwin ^b   Van Stone, John ^b   Levey, Andrew ^b   Meyer, Klemens B ^b   Klag, Michael J ^b   Johnson, H Keith ^b   Clark, Eugene ^b   Sadler, John H ^b   Teredesai, Pradip ^b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Anti hypertensive drugs; Cardiovascular cerebrovascular mortality; Dialysis; Hypertension; Survival

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; DIASTOLIC BLOOD PRESSURE; FEMALE; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 7344265050     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00005.x     Document Type: Article

References (49)

1. BURT VL, WHELTON P, ROCCELLA EJ, BROWN C, CUTLER JA, HIGGINS M, HORAN MJ, LABARTHE D: Prevalence of hypertension in the US adult population: Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 25:305-313, 1995
2. THE FIFTH REPORT OF THE JOINT NATIONAL COMMITTEE ON DETECTION, EVALUATION, AND TREATMENT OF HIGH BLOOD PRESSURE (JNC V): Arch Intern Med 153:154-183, 1993
3. SYTKOWSKI P, D'AGOSTINO R, BELANGER A, KANNEL WB: Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality: The Framingham Heart Study 1950 to 1990. Circulation 93:697-703, 1996
4. VETERANS ADMINISTRATION COOPERATIVE STUDY GROUP ON ANTIHYPERTENSIVE AGENTS: Effects of treatment on morbidity in hypertension: II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 213:1143-1152, 1970
5. THE HYPERTENSION DETECTION, FOLLOW-UP PROGRAM COOPERATIVE GROUP: Five-year findings of the hypertensive detection and follow-up program: I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 242:2562-2571, 1979
6. THE HYPERTENSION DETECTION, FOLLOW-UP PROGRAM COOPERATIVE GROUP: Five-year findings of the hypertension detection and follow-up program: II. Mortality by race-sex and age. JAMA 242:2572-2577, 1979
7. THE HYPERTENSION DETECTION, FOLLOW-UP PROGRAM COOPERATIVE GROUP: Five-year findings of the hypertension detection and follow-up program: III. Reduction in stroke incidence among persons with high blood pressure. JAMA 247:633-638, 1982
8. THE MULTIPLE RISK FACTOR INTERVENTION TRIAL RESEARCH GROUP: Multiple risk factor intervention trial: Risk factor changes and mortality results. JAMA 248:1465-1477, 1982
9. SHEP COOPERATIVE RESEARCH GROUP: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the systolic hypertension in the elderly program (SHEP). JAMA 265:3255-3264, 1991
10. LINDEMAN RD, TOBIN JD, SHOCK NW: Association between blood pressure and the rate of decline in renal function with age. Kidney Int 26:861-868, 1984
11. KLAG MJ, WHELTON PK, RANDALL BL, NEATON JD, BRANCATI FL, FORD CE, SHULMAN NB, STAMLER J: Blood pressure and end-stage renal disease in men. N Engl J Med 334:13-18, 1996
12. 1995 Core Indicators Project initial results. Opportunities to Improve Care for Adult In-Center Hemodialysis Patients. Department of Health and Human Services, Health Care Financing Administration, Health Standards and Quality Bureau, Baltimore, January 1996
13. STOKES GS, MANI MK, STEWART JH: Relevance of salt, water, and renin to hypertension in chronic renal failure. Br Med J 3:126, 1970
14. ACOSTA JH: Hypertension in chronic renal disease. Kidney Int 22:702-712, 1982
15. LAMEIRE N, BERNAERT P, LAMBERT M-C, VIJT D: Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis. Kidney Int 48(Suppl 46):S31-S38, 1994
16. FOLEY RN, PARFREY PS, HARNETT JD, KENT GM, MURRAY DC, BARRE PE: Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 49:1379-1385, 1996
17. CHARRA B, CALEMARD E, RUFFET M, CHAZOT C, TERRAT J-C, VANEL T, LAURENT G: Survival as an index of adequacy of dialysis. Kidney Int 41:1286-1291, 1992
18. FERNANDEZ JM, CARBONELL ME, MAZZUCHI N, PETRUCCELLI D: Simultaneous analysis of morbidity and mortality factors in chronic hemodialysis patients. Kidney Int 41:1029-1034, 1992
19. NEFF MS, EISER AR, SLIFKIN RF, BAUM M, BAEZ A, GUPTA S, AMARGA E: Patients surviving 10 years of dialysis. Am J Med 74:996-1004, 1983
20. HARNETT JD, FOLEY RN, KENT GM, BARRE PE, MURRAY D, PARFREY PS: Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors. Kidney Int 47:884-890, 1995
21. ISEKI K, FUKIYAMA K: Predictors of stroke in patients receiving chronic hemodialysis. Kidney Int 50:2672-1675, 1996
22. ZAGER P, CAMPBELL M, BROWN R, PETERSON D: Effect of blood pressure (BP) on survival of hemodialysis (HD) patients. (abstract) J Am Soc Nephrol 6:654, 1995
23. SALEM MM, BOWER J: Hypertension in the hemodialysis population: Any relation to one-year survival? Am J Kidney Dis 28:737-740, 1996
24. DURANTI E, IMPERIALI P, SASDELLI M: Is hypertension a mortality risk factor in dialysis? Kidney Int 49(Suppl 55):S173-S174, 1996
25. CRUICKSHANK J: Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction. Br Med J 297:1227-1230, 1988
26. FARNETT L, MULROW C, LINN W, LUCEY C, TULEY M: The J-curve phenomenon and the treatment of hypertension: Is there a point beyond which pressure reduction is dangerous? JAMA 265:489-495, 1991
27. FLETCHER A, BULPITT C: How far should blood pressure be lowered? N Engl J Med 326:251-254, 1992
28. STEWART I: Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension. Lancet i:861-865, 1979
29. CRUICKSHANK J, THORP J, ZACHARIAS F: Benefits and potential harm of lowering high blood pressure. Lancet i:581-584, 1987
30. ALDERMAN M, OOI W, MADHAVAN S, COHEN H: Treatment-induced blood pressure reduction and the risk of myocardial infarction. JAMA 262:920-924, 1989
31. COOPER SP, HARDY RJ, LABARTHE DR, HAWKINS CM, SMITH ED, BLAUFOX MD, COOPER CJ, ENTWISLE G, MAXWELL MX: The relation between degree of blood pressure reduction and mortality among hypertensives in the hypertension detection and follow-up program. Am J Epidemiol 127:387-403, 1988
32. STAESSEN J, BULPITT C, CLEMENT D, DE LEEUW P, FLETCHER A, FORETTE F, LEONETTI G, NISSINEN A, O'MALLEY K, TUOMILEHTO J, WEBSTER J, WILLIAMS BO: Relation between mortality and treated blood pressure in elderly patients with hypertension: Report of the European working party on high blood pressure in the elderly. Br Med J 298:1552-1556, 1989
33. U.S. Renal Data System 1992 Annual Report: IV. Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients. Am J Kidney Dis (Suppl 2):32-38, 1992
34. DAUGIRDAS JT: Second generation logarithmic estimates of single-pool variables volume Kt/V: An analysis of error. J Am Soc Nephrol 4:1205-1213, 1993
35. SAS INSTITUTE, INC: SAS Software. Cary, SAS Institute, Inc., 1996
36. U.S. RENAL DATA SYSTEM: USRDS 1997 Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, April 1997
37. COLLINS AJ, MA JZ, UMEN A, KESHAVIAH P: Urea index and other predictors of hemodialysis patient survival. Am J Kidney Dis 23:272-282, 1994
38. VERTES V, CANGIANO JL, BERMAN LB, GOULD A: Hypertension in end-stage renal disease. N Engl J Med 280:978-998, 1969
39. LOWRIE EG, LEW NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458-482, 1990
40. HELD PJ, PORT FK, WOLFE RA, STANNARD DC, CARROLL CE, DAUGIRDAS JT, BLOEMBERGEN WE, GREER JW, HAKIM RM: The dose of dialysis and patient mortality. Kidney Int 50:550-556, 1996
41. U.S. RENAL DATA SYSTEM: USRDS 1996 Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, April 1996
42. CONVERSE RL, JACOBSEN TN, TOTO RD, JOST CM, COSENTINO F, FOUAD-TARAZI F, VICTOR RG: Sympathetic over activity in patients with chronic renal failure. N Engl J Med 327:1912-1918, 1992
43. VINCENTI F, AMEND W, ABELE J, FEDUSKA N, SALVATIERRA O: The role of hypertension in hemodialysis-associated atherosclerosis. Am J Med 68:363-369, 1980
44. MACMAHON S, PETO R, CUTLER J, COLLINS R, SORLIE P, NEATON J, ABBOT R, GODWIN J, DYER A, STAMLER J: Blood pressure, stroke, and coronary heart disease. Part I. Prolonged differences in blood pres-sure: Prospective observational studies corrected for the regression dilution bias. Lancet 335:765-774, 1990
45. COLLINS R, PETO R, MACMAHON S, HERBERT P, FIEBACH NH, EBERLEIN KA, GODWIN J, QIZILBASH N, TAYLOR JO, HENNEKENS CH: Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context. Lancet 335:827-838, 1990
46. THE HOT STUDY GROUP: The Hypertension Optimal Treatment (HOT) Study-A prospective study of the optimal therapeutic goal and the value of low-dose aspirin in anti-hypertensive treatment. Blood Press 4:312-318, 1993
47. RODBY RA, VONESH EF, KORBET SM: Blood pressure in hemodialysis and peritoneal dialysis using ambulatory blood pressure monitoring. Am J Kidney Dis 23:401-411, 1994
48. CHEIGH JS, MILITE C, SULLIVAN JF, RUBIN AL, STENZEL KH: Hypertension is not adequately controlled in hemodialysis patients. Am J Kidney Dis 19:453-459, 1992
49. HALEY WE, WOOD MG, ZACHARIAH PK: Left ventricular hyperthrophy, fluid weight change and circadian blood pressure pattern in hemodialysis patients. (abstract) Am J Hypertens 7:129A, 1994